Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Welliver

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
The Pediatric Infectious Disease Journal|December 1, 1996
Prevention of respiratory syncytial virus infection in high risk infants: consensus opinion on the role of immunoprophylaxis with respiratory syncytial virus hyperimmune globulinH C Meissner, R C Welliver, S A Chartrand, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 26, 2011
Effect of enhanced ultraviolet germicidal irradiation in the heating ventilation and air conditioning system on ventilator-associated pneumonia in a neonatal intensive care unitR M Ryan, G E Wilding, R J Wynn, et al.
The Journal of Pediatrics|August 1, 1996
Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk childrenE A Simoes, J R Groothuis, D A Tristram, et al.
The Journal of Pediatrics|October 27, 1998
Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study GroupE A Simoes, H M Sondheimer, F H Top, et al.
Journal of Medical Virology|September 26, 2000
Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c miceS M van Schaik, N Obot, G Enhorning, et al.
The Pediatric Infectious Disease Journal|March 27, 1999
Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinionH C Meissner, R C Welliver, S A Chartrand, et al.
Vaccine|August 1, 1995
Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infectionP A Piedra, W P Glezen, J A Kasel, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1995
Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulinJ R Groothuis, E A Simoes, M V Lehr, et al.
Pharmacotherapy|January 1, 1995
Sepsis syndrome and associated sequelae in patients at high risk for gram-negative sepsisK Conboy, L S Welage, C A Walawander, et al.
American Journal of Diseases of Children (1960)|March 1, 1978
Measles revaccination. Persistence and degree of antibody titer by type of immune responseJ Deseda-Tous, J D Cherry, M J Spencer, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
The Pediatric Infectious Disease Journal|December 1, 1996
Prevention of respiratory syncytial virus infection in high risk infants: consensus opinion on the role of immunoprophylaxis with respiratory syncytial virus hyperimmune globulinH C Meissner, R C Welliver, S A Chartrand, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 26, 2011
Effect of enhanced ultraviolet germicidal irradiation in the heating ventilation and air conditioning system on ventilator-associated pneumonia in a neonatal intensive care unitR M Ryan, G E Wilding, R J Wynn, et al.
The Journal of Pediatrics|August 1, 1996
Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk childrenE A Simoes, J R Groothuis, D A Tristram, et al.
The Journal of Pediatrics|October 27, 1998
Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study GroupE A Simoes, H M Sondheimer, F H Top, et al.
Journal of Medical Virology|September 26, 2000
Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c miceS M van Schaik, N Obot, G Enhorning, et al.
The Pediatric Infectious Disease Journal|March 27, 1999
Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinionH C Meissner, R C Welliver, S A Chartrand, et al.
Vaccine|August 1, 1995
Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infectionP A Piedra, W P Glezen, J A Kasel, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1995
Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulinJ R Groothuis, E A Simoes, M V Lehr, et al.
Pharmacotherapy|January 1, 1995
Sepsis syndrome and associated sequelae in patients at high risk for gram-negative sepsisK Conboy, L S Welage, C A Walawander, et al.
American Journal of Diseases of Children (1960)|March 1, 1978
Measles revaccination. Persistence and degree of antibody titer by type of immune responseJ Deseda-Tous, J D Cherry, M J Spencer, et al.
Pageof 9